Bronchiolitis, Viral Clinical Trial
Official title:
Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis
The purpose of this study is to more rigorously evaluate the response to a single bolus of magnesium sulfate in a population of patients with moderate to severe bronchiolitis. The primary outcome will be to evaluate the effect of this therapy on clinical respiratory status. Secondary outcomes of interest will include the incidence of adverse effects and safety profile of magnesium bolus use in this population.
This randomized placebo-controlled pilot study is designed to evaluate the above referenced outcomes. Study drug initiation will occur in the local pediatric intensive care unit in patients with a clinical diagnosis of bronchiolitis and whose parent/LAR consents for their participation. Our goal is to enroll and evaluate a total of 40 patients. Upon obtaining informed consent, the participant will receive an enrollment history and physical to include: baseline Modified Pulmonary Index Score (MPIS), blood pressure, vital signs, and epidemiologic data. The participant will then receive either a bolus of 50mg/kg Magnesium Sulfate (MgSO4) or normal saline as placebo medication over twenty minutes. Vital signs and MPIS will be monitored according to the study schedule, for a total of six hours. During the period of monitoring subjects will not receive additional bronchodilators unless otherwise deemed clinically necessary by the subject's attending physician. If administered, these will be recorded by investigative team. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04989114 -
Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis
|
N/A | |
Recruiting |
NCT04287959 -
SWISH Trial (Strategies for Weaning Infants on Supportive High Flow)
|
N/A | |
Not yet recruiting |
NCT01618175 -
Home Oxygen Treatment of Childhood Acute Bronchiolitis
|
N/A | |
Completed |
NCT01247064 -
Hypertonic Saline for Acute Bronchiolitis
|
Phase 4 | |
Completed |
NCT03062917 -
Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis
|
N/A | |
Recruiting |
NCT06030505 -
Effectiveness of Nirsevimab in Children Hospitalised With RSV Bronchiolitis
|
||
Completed |
NCT02571517 -
Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis
|
Phase 4 | |
Completed |
NCT02853838 -
Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)
|
N/A | |
Terminated |
NCT03252119 -
High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis
|
N/A | |
Terminated |
NCT03959384 -
Efficacy and Safety of Curosurf® in Patients Invasively Ventilated for Severe Bronchiolitis Under 12 Months of Age
|
Phase 3 | |
Completed |
NCT00119002 -
The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis
|
Phase 4 | |
Terminated |
NCT04221087 -
Steroid Use in Non-RSV Bronchiolitis
|
Phase 4 | |
Recruiting |
NCT04764929 -
Pediatric Helmet CPAP Pilot Study
|
N/A | |
Completed |
NCT00122785 -
Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children
|
N/A |